Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Penumbra Community
NYSE:PEN Community
1
Narratives
written by author
0
Comments
on narratives written by author
8
Fair Values set
on narratives written by author
Community Investing Ideas
Penumbra
Popular
Undervalued
Overvalued
Penumbra
AN
AnalystConsensusTarget
Consensus Narrative from 16 Analysts
STORM-PE Trial And New Therapies Will Expand Global Reach
Key Takeaways New clinical trials and innovative product launches are expected to drive market adoption, improve margins, and accelerate growth in large, underpenetrated therapy areas. Expanding globally with an enhanced sales force and continued investment in data and technology supports sustainable earnings, better pricing, and long-term competitive strength.
View narrative
US$310.88
FV
14.8% undervalued
intrinsic discount
13.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
PEN
PEN
Penumbra
Your Fair Value
US$
Current Price
US$264.74
10.9% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-19m
2b
2015
2018
2021
2024
2025
2027
2030
Revenue US$2.2b
Earnings US$258.1m
Advanced
Set Fair Value